<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Accumulation of p53 protein was determined by immunohistochemistry in archival material of biopsy specimens from 102 patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with different grades of <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, in 24 oesophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> associated with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, and in 23 cases of metaplastic epithelium adjacent to these <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Immunostaining for the p53 protein was found in 23/102 (23 per cent) cases of the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> biopsies and in 12/23 (52 per cent) cases of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> adjacent to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Significant correlations were found between the grade of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and p53 immunoreactivity in both Barrett's biopsies without <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P &lt; 0.001) and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> adjacent to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>In the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, intense nuclear immunohistochemical staining for p53 was diffusely or focally present in 20/24 (83 per cent) of the specimens </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, p53 is a progression marker with high expression in high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (89 per cent) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (83 per cent) </plain></SENT>
</text></document>